Landsberg Bennett & Dubbaneh’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Landsberg Bennett & Dubbaneh’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$975K	Sell	7,727 -158	-2%	-$20.3K	0.12%	124
2021 Q2	$1.07M	Sell	7,885 -148	-2%	-$19.5K	0.14%	120
2021 Q1	$1.1M	Sell	8,033 -36,159	-82%	-$5.41M	0.16%	116
2020 Q4	$6.22M	Sell	44,192 -140	-0.3%	-$17.9K	0.95%	24
2020 Q3	$4.95M	Sell	44,332 -7,225	-14%	-$810K	0.87%	27
2020 Q2	$5.69M	Buy	51,557 +565	+1%	+$55.6K	1.18%	15
2020 Q1	$3.87M	Sell	50,992 -3,597	-7%	-$319K	1.08%	27
2019 Q4	$5.17M	Sell	54,589 -792	-1%	-$68.5K	1.21%	17
2019 Q3	$4.23M	Sell	55,381 -727	-1%	-$60.4K	1.14%	18
2019 Q2	$4.95M	Sell	56,108 -4,235	-7%	-$361K	1.3%	13
2019 Q1	$5.59M	Buy	60,343 +28,573	+90%	+$2.43M	1.32%	15
2018 Q4	$2.28M	Buy	+31,770	New	+$2.56M	0.87%	30

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Landsberg Bennett & Dubbaneh's XBI Position: Q3 2021 in Review

Landsberg Bennett & Dubbaneh reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 2% in Q3 2021, selling an estimated $20.3K and leaving 7,727 shares worth $975K. The position accounts for 0.12% of the portfolio, ranked #124.

Landsberg Bennett & Dubbaneh first reported a position in XBI in Q4 2018 and has held it in 12 quarters since. The position peaked at $6.22M in Q4 2020. 635 funds tracked by Wall St. Rank hold XBI as of Q3 2021.

Landsberg Bennett & Dubbaneh held 7,727 shares of State Street SPDR S&P Biotech ETF worth $975K as of Q3 2021.
Landsberg Bennett & Dubbaneh sold 158 State Street SPDR S&P Biotech ETF shares in Q3 2021, an estimated $20.3K.
State Street SPDR S&P Biotech ETF made up 0.12% of Landsberg Bennett & Dubbaneh's portfolio in Q3 2021, its #124 holding.
Landsberg Bennett & Dubbaneh first reported a position in State Street SPDR S&P Biotech ETF in Q4 2018 and has held it in 12 quarters since.
Landsberg Bennett & Dubbaneh's State Street SPDR S&P Biotech ETF position peaked at $6.22M in Q4 2020.
635 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2021.

Based on Landsberg Bennett & Dubbaneh's 13F filing for Q3 2021, filed 29 Oct 2021.